In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Cathie Wood’s ARK ETFs have made their daily trades for Thursday, 29 May 2025, with a notable increase in shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and a continued sell-off of Adaptive ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions ...

NSW Minister for Industry and Trade Anoulack Chanthivong has returned from a successful trade mission to the Republic of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that ...

"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Genscript Biotech ( ($HK:1548) ) just unveiled an announcement. Genscript Biotech Corporation held its Annual General Meeting on May 29, 2025, ...

Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...